DDAVP injection and Insulin aspart, recombinant Subcutaneous
Determining the interaction of DDAVP injection and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: desmopressin
Brand name: DDAVP, Nocdurna, DDAVP nasal, DDAVP Rhinal Tube, Noctiva, Stimate
Synonyms: DDAVP (injection), DDAVP
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- DDAVP injection-Insulin degludec
- DDAVP injection-Insulin Degludec (U-100) Prefilled Pens
- DDAVP injection-Insulin Degludec (U-100) Vials
- DDAVP injection-Insulin Degludec (U-200) Prefilled Pens
- DDAVP injection-Insulin degludec and liraglutide
- DDAVP injection-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-DDAVP nasal
- Insulin aspart, recombinant Subcutaneous-DDAVP Nasal Spray
- Insulin aspart, recombinant Subcutaneous-DDAVP Oral
- Insulin aspart, recombinant Subcutaneous-DDAVP Rhinal Tube
- Insulin aspart, recombinant Subcutaneous-DDAVP Rhinal Tube nasal
- Insulin aspart, recombinant Subcutaneous-DDAVP Tablets